This $2,112,000.00 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at the Fred Hutchinson Cancer Center in Seattle, Washington to investigate the prevention of liver metastasis by defining regulators of tumor dormancy, how they are disrupted, and how to reverse it. The research aims to transform healthcare for military service members and the broader...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,292,000.00 to the University of California, San Francisco (UCSF) to conduct in vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer. The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical investigations. The 4-year research project will involve...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,615,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at "DISCOVERING TRANSCRIPTIONAL DRIVERS OF THERAPY-RESISTANT METASTATIC PROSTATE CANCER". The award period runs from May 1, 2024 to April 30, 2027. As a leading academic medical center, UCSF has a strong track record of...
The Regents of the University of California, San Francisco will receive $4.8 million over four years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to reveal and target multiple pathways of breast cancer metastasis, with the goal of transforming healthcare for service members and the public through innovative biomedical research focused on investigating medical...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,008,313 to The Regents of the University of California, San Francisco (UCSF) for a 3-year period from Sep 1, 2024 to Aug 31, 2027. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. UCSF, a prominent academic medical center and research institution,...
This $1,339,689 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by The Feinstein Institutes for Medical Research to identify and characterize metastasis-driving tumor cell subpopulations in localized stage III clear cell renal cell carcinoma. The 4-year award from Aug 1, 2024 to Jul 31, 2028 will support this advanced biomedical research initiative focused on transforming healthcare for military...
The Department of Defense's Defense Health Agency awarded a $1,041,595 Project Grant to The Regents of the University of California, San Francisco (UCSF) through the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Melanoma Research Program Team Science Award," will fund innovative biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Spanning from September 1, 2024 to August 31,...
This federal Project Grant award, valued at $1,030,660.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will conduct scientific investigations spanning basic, applied, and...
The Department of the Army Medical Command awarded a $161,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) to conduct research on "Deciphering Translational Control of Androgen Receptor in Prostate Cancer". The grant project will run from April 1, 2024 to March 31, 2026. As a leading academic medical center and research institution, UCSF has extensive expertise in federal...
The Department of the Army Medical Command has awarded a $656,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Regents of the University of California, San Francisco (UCSF). The federal grant will fund research to investigate the role of myeloid cells and other inflammatory components in the progression of Barrett's esophagus to invasive esophageal adenocarcinoma. The award period runs from May 15, 2025, to May 14, 2027. As a leading academic...